Sana Ali, MD
Medical Oncology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ali’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$349,475
Pharmacies billed $349,475 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
59 generic and 35 brand-name prescriptions · $349,475 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 94 | 40 | None | 37% | $349,475 |
| 2023 | 217 | 39 | None | None | $62,745 |
| 2022 | 126 | 35 | 0% (0) | None | $7,216 |
| 2021 | 16 | None | 0% (0) | None | $282 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Atorvastatin | 22 | $261 | $12 |
| Metformin | 17 | $203 | $12 |
2022: 1 drug
| Furosemide | 11 | $117 | $11 |
Money from drug and device companies
$1,232 in 2025
| 2025 | 17 | 50 | None | $1,232 |
| 2024 | 19 | 46 | None | $1,182 |
| 2023 | 8 | 18 | None | $495 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Fabhalta | $412 | 18 payments
|
| Janssen Biotech | Tecvayli | $125 | 5 payments
|
| Incyte | Monjuvi | $116 | 4 payments
|
| Merck Sharp & Dohme | Keytruda | $110 | 4 payments
|
| Alexion Pharmaceuticals | Ultomiris | $55 | 3 payments
|
| Daiichi Sankyo | Enhertu | $52 | 2 payments
|
See all 50 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-08 | Scemblix | $77 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Fabhalta | $25 |
| Incyte | Meals · 2025-11-04 | Jakafi | $28 |
| Merck Sharp & Dohme | Meals · 2025-10-28 | Keytruda Qlex | $28 |
| Genzyme | Meals · 2025-10-27 | Sarclisa | $40 |
| Novartis Pharmaceuticals | Meals · 2025-10-15 | Fabhalta | $33 |
| Novartis Pharmaceuticals | Meals · 2025-10-14 | Scemblix | $28 |
| Incyte | Meals · 2025-10-02 | Monjuvi | $30 |
| Novartis Pharmaceuticals | Meals · 2025-09-25 | Fabhalta | $30 |
| Novartis Pharmaceuticals | Meals · 2025-09-17 | Scemblix | $26 |
| Novartis Pharmaceuticals | Meals · 2025-08-29 | Fabhalta | $30 |
| Janssen Biotech | Meals · 2025-08-18 | Carvykti | $21 |
| Novartis Pharmaceuticals | Meals · 2025-07-24 | Fabhalta | $25 |
| Incyte | Meals · 2025-07-17 | Monjuvi | $30 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Fabhalta | $19 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Fabhalta | $1 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Fabhalta | $0 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Fabhalta | $1 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Fabhalta | $0 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Fabhalta | $1 |
| Alexion Pharmaceuticals | Meals · 2025-06-25 | Ultomiris | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-18 | Enhertu | $32 |
| Abbvie | Meals · 2025-06-11 | Venclexta | $24 |
| Agios Pharmaceuticals | Meals · 2025-05-28 | Pyrukynd | $19 |
| Novartis Pharmaceuticals | Meals · 2025-05-22 | Scemblix | $26 |
| Blueprint Medicines | Meals · 2025-05-08 | Ayvakit | $25 |
| Pfizer | Meals · 2025-05-02 | Elrexfio | $30 |
| Gilead Sciences | Meals · 2025-04-28 | None | $28 |
| Janssen Biotech | Meals · 2025-04-24 | Tecvayli | $22 |
| Incyte | Meals · 2025-04-22 | Jakafi | $28 |
| Syndax Pharmaceuticals | Meals · 2025-04-10 | None | $32 |
| Blueprint Medicines | Meals · 2025-04-02 | Ayvakit | $18 |
| Alexion Pharmaceuticals | Meals · 2025-03-29 | Ultomiris | $16 |
| Daiichi Sankyo | Meals · 2025-03-27 | Vanflyta | $25 |
| Novartis Pharmaceuticals | Meals · 2025-03-25 | Fabhalta | $32 |
| Novartis Pharmaceuticals | Meals · 2025-03-05 | Fabhalta | $28 |
| Merck Sharp & Dohme | Meals · 2025-03-04 | Keytruda | $26 |
| Janssen Biotech | Meals · 2025-02-24 | Darzalex | $35 |
| Daiichi Sankyo | Meals · 2025-02-19 | Enhertu | $28 |
| Agios Pharmaceuticals | Meals · 2025-02-05 | Pyrukynd | $28 |
| Merck Sharp & Dohme | Meals · 2025-02-04 | Keytruda | $24 |
| Pfizer | Meals · 2025-01-26 | Bosulif | $17 |
| Novartis Pharmaceuticals | Meals · 2025-01-23 | Scemblix | $31 |
| Alexion Pharmaceuticals | Meals · 2025-01-23 | Ultomiris | $23 |
| Deciphera Pharmaceuticals | Meals · 2025-01-21 | Qinlock | $22 |
| Janssen Biotech | Meals · 2025-01-16 | Tecvayli | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-15 | None | $17 |
| Merck Sharp & Dohme | Meals · 2025-01-07 | Keytruda | $31 |
| Janssen Biotech | Meals · 2025-01-06 | Tecvayli | $24 |
| Karyopharm Therapeutics | Meals · 2025-01-02 | Xpovio | $29 |
See earlier years (2024, 2023)
2024: $1,182
| Abbvie | Venclexta | $189 | 5 payments
|
| Alexion Pharmaceuticals | Ultomiris | $166 | 6 payments
|
| Novartis Pharmaceuticals | Kesimpta | $145 | 2 payments
|
| EMD Serono | None | $103 | 3 payments
|
| Servier Pharmaceuticals | Asparlas | $73 | 3 payments
|
| Celgene | Reblozyl | $60 | 2 payments
|
| Janssen Biotech | Tecvayli | $57 | 1 payment
|
| Incyte | Pemazyre | $55 | 2 payments
|
| Genentech USA | Herceptin | $51 | 2 payments
|
| Pfizer | Ibrance | $35 | 1 payment
|
| Genzyme | Sarclisa | $34 | 2 payments
|
| Gilead Sciences | None | $33 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $33 | 2 payments
|
| Puma Biotechnology | None | $30 | 1 payment
|
| Kyowa Kirin | Poteligeo | $29 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $26 | 1 payment
|
| Daiichi Sankyo | Enhertu | $23 | 1 payment
|
| Coherus Biosciences | Udenyca | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $17 | 1 payment
|
2023: $495
| Abbvie | Venclexta | $132 | 5 payments
|
| Genzyme | Jevtana | $130 | 4 payments
|
| Celgene | Reblozyl | $78 | 3 payments
|
| EMD Serono | Bavencio | $57 | 2 payments
|
| Daiichi Sankyo | Enhertu | $29 | 1 payment
|
| Incyte | Jakafi | $29 | 1 payment
|
| Merck Sharp & Dohme | Prevymis | $23 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $16 | 1 payment
|
Professional record
- NPI
- 1841819349
More record details
- Sole proprietor
- No
- Taxonomy
- Medical oncology (207RX0202X); Internal medicine (207R00000X); Federal specialty code 207RH0000X (207RH0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2020-04-14
- NPI last updated
- 2026-09-17
- NPI record certified
- 2026-09-17
This is when the NPI record was last certified, not a medical board exam.